{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:29:11Z","timestamp":1793276951248,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jfas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Foot and Ankle Surgery"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1053\/j.jfas.2026.07.011","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:21:13Z","timestamp":1785169273000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["\u201cExamining the impact of perioperative glucagon-like-peptide-1 use within foot and ankle surgery: A systematic review of comparative studies\u201d"],"prefix":"10.1053","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9135-0484","authenticated-orcid":false,"given":"Omkar S.","family":"Anaspure","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8488-0691","authenticated-orcid":false,"given":"Pranav","family":"Sivaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4978-227X","authenticated-orcid":false,"given":"Prajwal","family":"Guruprasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aryan S.","family":"Anaspure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishin J.","family":"Kadakia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert T.","family":"Anastasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1053\/j.jfas.2026.07.011_bib0001","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1053\/j.jfas.2026.07.011_bib0002","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/SLA.0000000000006614","article-title":"Association of perioperative glucagon-like peptide-1 receptor agonist use and postoperative outcomes","volume":"281","author":"Aschen","year":"2025","journal-title":"Ann Surg"},{"issue":"12","key":"10.1053\/j.jfas.2026.07.011_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.arth.2025.06.083","article-title":"The association between glucagon-like peptide-1 receptor agonists and postoperative complications after arthroplasty: a systematic review and meta-analysis","volume":"40","author":"Chan","year":"2025","journal-title":"J Arthroplasty"},{"issue":"12","key":"10.1053\/j.jfas.2026.07.011_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.arth.2024.05.079","article-title":"Decreased risk of readmission and complications with preoperative GLP-1 analog use in patients undergoing primary total joint arthroplasty","volume":"39","author":"Buddhiraju","year":"2024","journal-title":"J Arthroplasty"},{"issue":"3","key":"10.1053\/j.jfas.2026.07.011_bib0005","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIR.0000000000001153","article-title":"American heart association council on peripheral vascular disease; council on hypertension; and council on lifestyle and cardiometabolic health health disparities in peripheral artery disease: a scientific statement from the american heart association","volume":"148","author":"Allison","year":"2023","journal-title":"Circulation"},{"issue":"16","key":"10.1053\/j.jfas.2026.07.011_bib0006","doi-asserted-by":"crossref","DOI":"10.5435\/JAAOS-D-24-00500","article-title":"Nonunion in foot and ankle arthrodesis surgery: review of risk factors, identification of high-risk patients, and a guide to perioperative testing and optimization","volume":"33","author":"Greene","year":"2024","journal-title":"J Am Acad Orthop Surg"},{"issue":"10","key":"10.1053\/j.jfas.2026.07.011_bib0007","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2106\/JBJS.L.01302","article-title":"Neuropathy and poorly controlled diabetes increase the rate of surgical site infection after foot and ankle surgery","volume":"96","author":"Wukich","year":"2014","journal-title":"J Bone Joint Surg Am"},{"issue":"2","key":"10.1053\/j.jfas.2026.07.011_bib0008","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2106\/JBJS.I.00080","article-title":"Postoperative infection rates in foot and ankle surgery: a comparison of patients with and without diabetes mellitus","volume":"92","author":"Wukich","year":"2010","journal-title":"J Bone Joint Surg Am"},{"issue":"5","key":"10.1053\/j.jfas.2026.07.011_bib0009","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/j.jfas.2021.03.011","article-title":"Insulin dependence increases the risk of 30-day postoperative complications following ankle fracture surgery in patients with diabetes mellitus","volume":"60","author":"Liu","year":"2021","journal-title":"J Foot Ankle Surg"},{"issue":"8","key":"10.1053\/j.jfas.2026.07.011_bib0010","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.injury.2020.05.006","article-title":"The effect of obesity on post-operative complications and functional outcomes after surgical treatment of torsional ankle fracture: a matched cohort study","volume":"51","author":"Benedick","year":"2020","journal-title":"Injury"},{"issue":"1","key":"10.1053\/j.jfas.2026.07.011_bib0011","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1186\/s13018-023-04110-y","article-title":"Effect of diabetes mellitus on the outcomes of total ankle arthroplasty: is controlled diabetes mellitus a risk factor?","volume":"18","author":"Lee","year":"2023","journal-title":"J Orthop Surg Res"},{"issue":"21","key":"10.1053\/j.jfas.2026.07.011_bib0012","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.5435\/JAAOS-D-24-01284","article-title":"The effects of glucagon-like peptide-1 agonist therapy on risk of infection, fracture, and early revision in primary total joint arthroplasty","volume":"33","author":"Levidy","year":"2025","journal-title":"J Am Acad Orthop Surg"},{"issue":"1","key":"10.1053\/j.jfas.2026.07.011_bib0013","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"9","key":"10.1053\/j.jfas.2026.07.011_bib0014","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J Surg. Sep"},{"issue":"3","key":"10.1053\/j.jfas.2026.07.011_bib0015","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.fas.2020.12.004","article-title":"Modified Brostrom repair with suture tape augmentation for lateral ankle instability: a systematic review","volume":"27","author":"Lewis","year":"2021","journal-title":"Foot Ankle Surg"},{"issue":"6","key":"10.1053\/j.jfas.2026.07.011_bib0016","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/10711007251328370","article-title":"GLP-1 agonists' effect on infection and union after tibiotalar fusion, subtalar fusion, triple arthrodesis","volume":"46","author":"Levidy","year":"2025","journal-title":"Foot Ankle Int"},{"issue":"5","key":"10.1053\/j.jfas.2026.07.011_bib0017","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1053\/j.jfas.2025.05.002","article-title":"Impact of glucagon-like peptide-1 receptor agonists on postoperative outcomes following ankle fracture open reduction and internal fixation","volume":"64","author":"Morningstar","year":"2025","journal-title":"J Foot Ankle Surg"},{"issue":"16","key":"10.1053\/j.jfas.2026.07.011_bib0018","doi-asserted-by":"crossref","DOI":"10.5435\/JAAOS-D-25-00439","article-title":"Reduced 90-day cardiovascular and infectious complications after open reduction internal fixation of ankle fractures in type II diabetic patients using semaglutide preoperatively","volume":"33","author":"Seddio","year":"2025","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1053\/j.jfas.2026.07.011_bib0019","doi-asserted-by":"crossref","DOI":"10.1097\/BRS.0000000000005466","article-title":"Are GLP-1 receptor agonists safe in spine surgery: a systematic review","author":"Younus","year":"2025","journal-title":"Spine (Phila Pa 1976)"},{"issue":"12","key":"10.1053\/j.jfas.2026.07.011_bib0020","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1016\/j.arth.2025.07.015","article-title":"Impact of glucagon-like peptide-1 receptor agonists on postoperative outcomes in arthroplasty: a systematic review","volume":"40","author":"Lee","year":"2025","journal-title":"J Arthroplasty"},{"key":"10.1053\/j.jfas.2026.07.011_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1379189","article-title":"Anti-inflammatory effect of semaglutide: updated systematic review and meta-analysis","volume":"11","author":"Masson","year":"2024","journal-title":"Front Cardiovasc Med"},{"issue":"12","key":"10.1053\/j.jfas.2026.07.011_bib0022","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1016\/j.jid.2025.08.045","article-title":"GLP-1 receptor agonists as emerging modulators of inflammation and angiogenesis in chronic cutaneous wound healing","volume":"145","author":"Ghebrehiwet-Kuflom","year":"2025","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1053\/j.jfas.2026.07.011_bib0023","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00574.2023","article-title":"GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage","volume":"326","author":"Park","year":"2024","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"8","key":"10.1053\/j.jfas.2026.07.011_bib0024","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/dom.14399","article-title":"Glucagon-like peptide-1 receptor agonists improve biomarkers of inflammation and oxidative stress: a systematic review and meta-analysis of randomised controlled trials","volume":"23","author":"Bray","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1053\/j.jfas.2026.07.011_bib0025","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2106\/JBJS.24.00468","article-title":"Glucagon-like peptide-1 receptor agonists decrease medical and surgical complications in morbidly obese patients undergoing primary TKA","volume":"107","author":"Kim","year":"2025","journal-title":"J Bone Joint Surg Am"},{"issue":"13","key":"10.1053\/j.jfas.2026.07.011_bib0026","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/BRS.0000000000005283","article-title":"Glucagon-like peptide-1 receptor agonist medications alter outcomes of spine surgery: a study among over 15,000 patients","volume":"50","author":"Wiener","year":"2025","journal-title":"Spine (Phila Pa 1976)"},{"issue":"4","key":"10.1053\/j.jfas.2026.07.011_bib0027","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/rheumatology\/keu464","article-title":"Obesity and osteoarthritis, more than just wear and tear: pivotal roles for inflamed adipose tissue and dyslipidaemia in obesity-induced osteoarthritis","volume":"54","author":"Thijssen","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"10472","key":"10.1053\/j.jfas.2026.07.011_bib0028","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(24)02322-5","article-title":"Osteoarthritis","volume":"405","author":"Kloppenburg","year":"2025","journal-title":"Lancet"},{"issue":"1","key":"10.1053\/j.jfas.2026.07.011_bib0029","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-17-0278","article-title":"Novel skeletal effects of glucagon-like peptide-1 (GLP-1) receptor agonists","volume":"236","author":"Mabilleau","year":"2018","journal-title":"J Endocrinol"},{"issue":"11","key":"10.1053\/j.jfas.2026.07.011_bib0030","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41584-025-01302-0","article-title":"Glucagon-like peptide-1 receptor agonists in arthritis: current insights and future directions","volume":"21","author":"Karacabeyli","year":"2025","journal-title":"Nat Rev Rheumatol"},{"issue":"21","key":"10.1053\/j.jfas.2026.07.011_bib0031","doi-asserted-by":"crossref","DOI":"10.1172\/JCI194751","article-title":"Antiinflammatory actions of glucagon-like peptide-1-based therapies beyond metabolic benefits","volume":"135","author":"Wong","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jfas.2026.07.011_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156113","article-title":"Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis","volume":"164","author":"Karakasis","year":"2025","journal-title":"Metabolism"},{"issue":"5","key":"10.1053\/j.jfas.2026.07.011_bib0033","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/14656566.2024.2343092","article-title":"A systematic review of the effect of semaglutide on lean mass: insights from clinical trials","volume":"25","author":"Bikou","year":"2024","journal-title":"Expert Opin Pharmacother"},{"issue":"10","key":"10.1053\/j.jfas.2026.07.011_bib0034","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2337\/dci23-0100","article-title":"Incretin-based weight loss pharmacotherapy: can resistance exercise optimize changes in body composition?","volume":"47","author":"Locatelli","year":"2024","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1053\/j.jfas.2026.07.011_bib0035","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1210\/clinem\/dgag052","article-title":"Skeletal effect of semaglutide and tirzepatide in patients with increased risk of fractures","volume":"111","author":"Liu","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.jfas.2026.07.011_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112924","article-title":"GLP-1 receptor agonists and sarcopenia: Weight loss at a cost? A brief narrative review","volume":"229","author":"Pantazopoulos","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"10.1053\/j.jfas.2026.07.011_bib0037","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/anae.16541","article-title":"Elective peri-operative management of adults taking glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter-2 inhibitors: a multidisciplinary consensus statement","volume":"80","author":"El-Boghdadly","year":"2025","journal-title":"Anaesthesia"},{"issue":"1 Suppl 1","key":"10.1053\/j.jfas.2026.07.011_bib0038","article-title":"Diabetes care in the hospital: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1053\/j.jfas.2026.07.011_bib0039","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/0310057X251355288","article-title":"2025 ADS\/ANZCA\/GESA\/NACOS clinical practice recommendations on the peri-procedural use of GLP-1\/GIP receptor agonists","volume":"53","author":"Hocking","year":"2025","journal-title":"Anaesth Intensive Care"},{"issue":"11","key":"10.1053\/j.jfas.2026.07.011_bib0040","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bjae.2022.07.005","article-title":"Regional anaesthesia for foot and ankle surgery","volume":"22","author":"Moosa","year":"2022","journal-title":"BJA Educ"},{"key":"10.1053\/j.jfas.2026.07.011_bib0041","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.knee.2025.08.007","article-title":"GLP-1 agonists are protective against postoperative complications following total knee arthroplasty","volume":"57","author":"Ranson","year":"2025","journal-title":"Knee"},{"key":"10.1053\/j.jfas.2026.07.011_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.arth.2025.06.083","article-title":"Glucagon-like peptide-1 receptor agonists, readmission, and postoperative complications in arthroplasty: a systematic review and meta-analysis","author":"Chan","year":"2025","journal-title":"J Arthroplasty"},{"issue":"7s1","key":"10.1053\/j.jfas.2026.07.011_bib0043","article-title":"Trends, demographics, and outcomes for glucagon-like peptide-1 receptor agonist use in total knee arthroplasty: an 11-year perspective","volume":"40","author":"Katzman","year":"2025","journal-title":"J Arthroplasty"},{"key":"10.1053\/j.jfas.2026.07.011_bib0044","article-title":"Association of preoperative GLP-1 receptor agonist use with outcomes after primary total knee arthroplasty","author":"Box","year":"2025","journal-title":"Knee"},{"issue":"8s1","key":"10.1053\/j.jfas.2026.07.011_bib0045","article-title":"GLP-1 agonists for weight loss: do they increase complications in non-diabetic patients undergoing primary total hip arthroplasty?","volume":"40","author":"Verhey","year":"2025","journal-title":"J Arthroplasty"},{"issue":"6","key":"10.1053\/j.jfas.2026.07.011_bib0046","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.14309\/ajg.0000000000002820","article-title":"Quantified metrics of gastric emptying delay by glucagon-like peptide-1 agonists: a systematic review and meta-analysis with insights for periprocedural management","volume":"119","author":"Hiramoto","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1053\/j.jfas.2026.07.011_bib0047","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1053\/j.gastro.2025.06.003","article-title":"Glucagon-like peptide-1 receptor agonists and gastrointestinal adverse events: a systematic review and meta-analysis","volume":"169","author":"Chiang","year":"2025","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1053\/j.jfas.2026.07.011_bib0048","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/phar.4607","article-title":"Incretin hormone agonists: current and emerging pharmacotherapy for obesity management","volume":"44","author":"Alhomoud","year":"2024","journal-title":"Pharmacotherapy"}],"container-title":["The Journal of Foot and Ankle Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S106725162600236X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S106725162600236X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T11:24:27Z","timestamp":1786101867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S106725162600236X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":48,"alternative-id":["S106725162600236X"],"URL":"https:\/\/doi.org\/10.1053\/j.jfas.2026.07.011","relation":{},"ISSN":["1067-2516"],"issn-type":[{"value":"1067-2516","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cExamining the impact of perioperative glucagon-like-peptide-1 use within foot and ankle surgery: A systematic review of comparative studies\u201d","name":"articletitle","label":"Article Title"},{"value":"The Journal of Foot and Ankle Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jfas.2026.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s).","name":"copyright","label":"Copyright"}]}}